Published February 1998 | Version v1
Journal article

The protective effect of Royal Jelly against the hemopoiesis dysfunction in X-irradiated mice

  • 1. Zeria Pharmaceutical Co., Ltd., Konan, Saitama (Japan). Central Research Laboratories

Description

The protective effect of Royal Jelly (RJ) against the hemopoietic dysfunction in whole body X-irradiated C57BL/6 mice was investigated. When RJ (1.0 g/kg, po or 0.5 g/kg, ip) was administered every day beginning two weeks before X-irradiation (10 Gy), a significant increase in the number of leukocytes and erythrocytes was observed in mice treated with RJ, as compared with X-irradiated control. In addition, the number of colony forming units in culture (CFU-C) of bone marrow cells or splenocytes was significantly increased in mice treated with RJ. Therefore, when granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) in peripheral blood was measured by ELISA kit, a significant increase in the amount of GM-CSF and IL-3 was observed. These results suggest that the protective effect of RJ against hemopoietic dysfunction could be expressed through an increase in the number of hemopoietic stem cells by the induction of hemopoietic factor such as GM-CSF and IL-3. (author)

Additional details

Publishing Information

Journal Title
Biotherapy
Journal Volume
12
Journal Issue
2
Journal Page Range
p. 313-319.
ISSN
0914-2223
CODEN
BITPE9